[EN] CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF<br/>[FR] INHIBITEURS DE CD73 ET LEURS UTILISATIONS PHARMACEUTIQUES
申请人:[en]RISEN (SUZHOU) PHARMA TECH CO., LTD.
公开号:WO2022109741A1
公开(公告)日:2022-06-02
CD73 (also known as ecto-5´-nucleotidase) inhibitor compounds are provided, as well as compositions and uses thereof for treating or preventing CD73-associated or related diseases, disorders and conditions, including cancer- and immune-related disorders. CD73 inhibitor compounds include compounds having the structure set forth in Formula I': (I') and pharmaceutically acceptable esters or salts thereof.